RGEN

Repligen Corporation

Healthcare›Medical - Instruments & Supplies|NASDAQ Global Select|US

Price

$117.78

Market Cap

$6.63B

Beta

1.18

P/E

141.4

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+16.36%

EPS Growth (YoY)+500.00%

Revenue CAGR 3Y-2.70%

P/E Ratio141.4

PEG Ratio0.28

FCF Yield+1.38%

Debt / Equity0.33

Interest Coverage1.2x

No credit card required

Already have an account? Sign in to view the full analysis for RGEN.